Search

Jianren Mao

from Lexington, MA
Age ~59

Jianren Mao Phones & Addresses

  • Lexington, MA
  • Sarasota, FL
  • Richmond, VA
  • Arlington, MA
  • Chestnut Hill, MA
  • Henrico, VA

Work

Company: Center For Pain Medicine Address: 15 Parkman St Suite 340, Boston, MA 02114 Phones: (617) 726-8810

Education

School / High School: Suzhou Medical College 1983

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Anesthesiology, 2000

Specialities

Pain Medicine

Professional Records

Medicine Doctors

Jianren Mao Photo 1

Dr. Jianren Mao, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Pain Medicine
Address:
Center For Pain Medicine
15 Parkman St Suite 340, Boston, MA 02114
(617) 726-8810 (Phone)
Certifications:
Anesthesiology, 2000
Pain Medicine, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Center For Pain Medicine
15 Parkman St Suite 340, Boston, MA 02114

Massachusetts General Hospital
55 Fruit Street, Boston, MA 02114
Education:
Medical School
Suzhou Medical College
Graduated: 1983
Medical School
Med College Va
Graduated: 1995
Medical School
Med College Va Hosps
Graduated: 1999
Medical School
Mass Genl Hospital Harvard Med School
Graduated: 2000
Jianren Mao Photo 2

Jianren Mao, Boston MA

View page
Specialties:
Anesthesiology
Pain Medicine
Pain Medicine
Work:
Massachusetts General Hospital
15 Parkman St, Boston, MA 02114
Education:
Suzhou Medical College (1983)
Jianren Mao Photo 3

Jianren M Mao, Boston MA

View page
Specialties:
Pain Management Specialist
Address:
15 Parkman St, Boston, MA 02114
149 13Th St, Charlestown, MA 02129
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology
American Board of Anesthesiology Sub-certificate in Pain Medicine (Anesthesiology)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jianren M. Mao
Jianren Mao MD,PHD
Anesthesiology · Pain Management
15 Parkman St, Boston, MA 02114
(617) 726-8810

Publications

Us Patents

Inhibiting The Development Of Tolerance To And/Or Dependence On An Addictive Substance

View page
US Patent:
RE39300, Sep 19, 2006
Filed:
Jun 15, 2001
Appl. No.:
09/880881
Inventors:
David J. Mayer - Richmond VA, US
Jianren Mao - Boston MA, US
Assignee:
Virginia Commonwealth University Medical College of Virginia - Richmond VA
International Classification:
A61K 31/70
A61K 31/54
A61K 31/44
A61K 31/445
US Classification:
514 25, 514216, 5142235, 5142245, 5142255, 5142312, 514282, 514304, 514305, 514306, 514307, 514812
Abstract:
Nontoxic substances that block the N-methyl-D-aspartate (NMDA) receptor, e. g. , a morphinan such as dextromethorphan or dextrorphan, or that block a major intracellular consequence of NMDA-receptor activation, e. g. , a ganglioside such as GMor GT, a phenothiazine such as trifluoperazine or a naphthalenesulfonamide such as N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, inhibit the development of tolerance to and/or dependence on addictive drugs, e. g. , narcotic analgesics such as morphine, codeine, etc.

Method And Apparatus For Patient-Controlled Medication Delivery

View page
US Patent:
20050234430, Oct 20, 2005
Filed:
Apr 15, 2004
Appl. No.:
10/825069
Inventors:
Jianren Mao - Arlington MA, US
Shihab Ahmed - Lincoln MA, US
International Classification:
A61K009/22
US Classification:
604890100, 128DIG013
Abstract:
A method and apparatus for providing patient-controlled medication delivery is presented. The apparatus includes a medication storage subsystem, an interval timer, a patient verification system coupled to the medication storage subsystem, and a delivery subsystem which delivers one of the prescribed amounts of medication if the interval timer has reached an end of a predetermined time interval and the patient verification system verifies an identity of the patient. The method for providing patient-controlled medication delivery includes verifying an identification of an intended patient and providing a first prescribed amount of a medication for the intended patient, wherein the intended patient determines a time to start taking the prescribed amount of the medication. The method further includes waiting a predetermined time interval, again verifying the identification of the intended patient and providing another prescribed amount of the medication for the intended patient.

Pain-Alleviating Drug Composition And Method For Alleviating Pain

View page
US Patent:
58639225, Jan 26, 1999
Filed:
Jul 7, 1997
Appl. No.:
8/889041
Inventors:
David J. Mayer - Richmond VA
Donald D. Price - Richmond VA
Jianren Mao - Richmond VA
John W. Lyle - Belmar NJ
Assignee:
Virginia Commonwealth University - Richmond VA
International Classification:
A61K 31505
A61K 31445
A61K 31165
US Classification:
514270
Abstract:
The analgesic effectiveness of a combination drug containing at least one analgesic is significantly enhanced by the addition of a nontoxic N-methyl-D-aspartate (NMDA) receptor antagonist thereto.

Inhibiting The Development Of Tolerance To And/Or Dependence On A Narcotic Addictive Substance

View page
US Patent:
53210123, Jun 14, 1994
Filed:
Apr 6, 1993
Appl. No.:
8/043280
Inventors:
David J. Mayer - Richmond VA
Donald D. Price - Richmond VA
Jianren Mao - Richmond VA
John W. Lyle - Belmar NJ
Assignee:
Virginia Commonwealth University Medical College - Richmond VA
International Classification:
A61K 3170
A61K 3155
A61K 3154
A61K 3144
US Classification:
514 25
Abstract:
Nontoxic substances that block the N-methyl-D-aspartate (NMDA) receptor, e. g. , a morphinan such as dextromethorphan or dextrorphan, or that block a major intracellular consequence of NMDA receptor activation, e. g. , a ganglioside such as GM. sub. 1 or GT. sub. 1b, a phenothiazine such as trifluoperazine or a naphthalenesulfonamide such as N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, inhibit the development of tolerance to and/or dependence on addictive drugs, e. g. , narcotic analgesics such as morphine, codeine, etc.

Inhibiting The Development Of Tolerance To And/Or Dependence On An Addictive Substance

View page
US Patent:
55568386, Sep 17, 1996
Filed:
May 19, 1994
Appl. No.:
8/245970
Inventors:
David J. Mayer - Richmond VA
Donald D. Price - Richmond VA
Jianren Mao - Richmond VA
John W. Lyle - Belmar NJ
Assignee:
Virginia Commonwealth University - Richmond VA
International Classification:
A61K 3170
A61K 3154
A61K 3144
A61K 31445
US Classification:
514 25
Abstract:
Nontoxic substances that block the N-methyl-D-aspartate (NMDA) receptor, e. g. , a morphinan such as dextromethorphan or dextrorphan, or that block a major intracellular consequence of NMDA-receptor activation, e. g. , a ganglioside such as GM. sub. 1 or GT. sub. 1b, a phenothiazine such as trifluoperazine or a naphthalenesulfonamide such as N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, inhibit the development of tolerance to and/or dependence on addictive drugs, e. g. , narcotic analgesics such as morphine, codeine, etc.

Method For The Treatment Of Chronic Pain

View page
US Patent:
53526830, Oct 4, 1994
Filed:
Mar 5, 1993
Appl. No.:
8/027177
Inventors:
David J. Mayer - Richmond VA
Donald D. Price - Richmond VA
Jianren Mao - Richmond VA
John W. Lyle - Belmar NJ
Assignee:
Virginia Commonwealth University Medical College of Virginia - Richmond VA
International Classification:
A61K 31485
US Classification:
514289
Abstract:
Chronic pain is alleviated in a mammal suffering therefrom by administering to the mammal a chronic pain alleviating amount of a nontoxic N-methyl-D-aspartate receptor antagonist such as dextromethorphan, dextrorphan, ketamine or pharmaceutically acceptable salt thereof, alone or in combination with a local anesthetic and optionally in sustained release dosage form.

Method And Composition For Alleviating Pain

View page
US Patent:
58344799, Nov 10, 1998
Filed:
Nov 6, 1996
Appl. No.:
8/746202
Inventors:
David J. Mayer - Richmond VA
Donald D. Price - Richmond VA
Jianren Mao - Richmond VA
John W. Lyle - Belmar NJ
International Classification:
A61K 31485
US Classification:
514289
Abstract:
The analgesic effectiveness of an NSAID is significantly enhanced by administering the NSAID prior to, with or following the administration of an analgesia enhancer which is a nontoxic NMDA receptor blocker and/or a nontoxic substance that blocks at least one major intracellular consequence of NMDA receptor activation.

Pain Alleviating Drug Composition And Method For Alleviating Pain

View page
US Patent:
58694986, Feb 9, 1999
Filed:
Jul 7, 1997
Appl. No.:
8/888728
Inventors:
David J. Mayer - Richmond VA
Donald D. Price - Richmond VA
Jianren Mao - Richmond VA
John W. Lyle - Belmar NJ
Assignee:
Virginia Commonwealth University - Richmond VA
International Classification:
A61K 31445
A61K 3119
US Classification:
514282
Abstract:
The analgesic effectiveness of a combination drug containing at least one analgesic is significantly enhanced by the addition of a nontoxic N-methyl-D-aspartate (NMDA) receptor antagonist thereto.
Jianren Mao from Lexington, MA, age ~59 Get Report